Thoracic endovascular aortic repair for type B aortic dissection patients: 11-year experience from a Chinese Tertiary Center

Abstract

Thoracic endovascular aortic repair (TEVAR) has been gradually considered as the mainstream therapy for type B aortic dissection (TBAD), especially for complicated acute TBAD, due to its minimally invasive nature and satisfactory clinical outcomes. Currently, our knowledge of aortic dissection and endovascular treatment is primarily derived from western registries including the International Registry of Acute Aortic Dissection (IRAD) and Vascular Quality Initiative (VQI), which includes few Asian TBAD patients without any Chinese population. Therefore, we report a long-term single-center experience of TBAD patients who underwent TEVAR in a Chinese high-volume tertiary center. The preliminary results would provide useful insight and enhances our understanding of this disease in the Chinese population.